Supreme Court medication abortion case threatens ‘seismic shift’ in FDA drug approval process, experts warn
The FDA’s mandate has created a trusted drug approval process that could be upended by a case about the medication abortion drug mifepristone that’s being argued Tuesday in front of the US Supreme Court, experts say.
